Genetics Schizopherenia Impact Factor
Schizophrenia is a
brain disorder classified as a psychosis, which means that it affects a person's thinking, sense of self, and perceptions. The disorder typically becomes evident during late adolescence or early adulthood.
Signs and symptoms of schizophrenia include false perceptions called hallucinations. Auditory hallucinations of voices are the most common hallucinations in schizophrenia, but affected individuals can also experience hallucinations of visions, smells, or touch (tactile) sensations. Strongly held false beliefs (delusions) are also characteristic of schizophrenia. For example, affected individuals may be certain that they are a particular historical figure or that they are being plotted against or controlled by others.
People with schizophrenia often have decreased ability to function at school, at work, and in social settings. Disordered thinking and concentration, inappropriate emotional responses, erratic speech and behavior, and difficulty with personal hygiene and everyday tasks can also occur. People with schizophrenia may have diminished facial expression and animation (flat affect), and in some cases become unresponsive (catatonic). Substance abuse and suicidal thoughts and actions are common in people with schizophrenia.
Certain movement problems such as tremors, facial tics, rigidity, and unusually slow movement (bradykinesia) or an inability to move (akinesia) are common in people with schizophrenia. In most cases these are side effects of medicines prescribed to help control the disorder. However, some affected individuals exhibit movement abnormalities before beginning treatment with medication.
High Impact List of Articles
-
The role of miRNAs in autoimmune inflammatory diseases
Federica Canzano, Alessia Paganelli, Paola Volpe & Roberto Paganelli
Short Communication: International Journal of Clinical Rheumatology
-
The role of miRNAs in autoimmune inflammatory diseases
Federica Canzano, Alessia Paganelli, Paola Volpe & Roberto Paganelli
Short Communication: International Journal of Clinical Rheumatology
-
Characteristics of fibromyalgia patients prescribed opioid medications: data from the Cleveland Clinic Fibromyalgia Registry
Sahar Kaouk, William S. Wilke & Carmen E. Gota
Research Article: International Journal of Clinical Rheumatology
-
Characteristics of fibromyalgia patients prescribed opioid medications: data from the Cleveland Clinic Fibromyalgia Registry
Sahar Kaouk, William S. Wilke & Carmen E. Gota
Research Article: International Journal of Clinical Rheumatology
-
Recurrent life-threatening bleeding due to acquired clotting factor XIII inhibitor in a Chinese patient with systemic lupus erythematosus
Jacky Ka Hing Chan & Chi Keung Ching
Case Report: International Journal of Clinical Rheumatology
-
Recurrent life-threatening bleeding due to acquired clotting factor XIII inhibitor in a Chinese patient with systemic lupus erythematosus
Jacky Ka Hing Chan & Chi Keung Ching
Case Report: International Journal of Clinical Rheumatology
-
Gout and the heart: beyond comorbidities
M Andres, F Sivera, M-A Quintanilla, P Vela & E Pascual
Special Issue Article: International Journal of Clinical Rheumatology
-
Gout and the heart: beyond comorbidities
M Andres, F Sivera, M-A Quintanilla, P Vela & E Pascual
Special Issue Article: International Journal of Clinical Rheumatology
-
Metabolomics in rheumatic diseases
A Julià, A Alonso & S Marsal
Review Article: International Journal of Clinical Rheumatology
-
Metabolomics in rheumatic diseases
A Julià, A Alonso & S Marsal
Review Article: International Journal of Clinical Rheumatology
Relevant Topics in Clinical